Yining Chen
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway.
Journal: Translational gastroenterology and hepatology
Published: September 19, 2024
Etomidate Improves Antitumor Immunity by Suppressing PD-L1 Expression in Hepatocellular Carcinoma Cells.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 08, 2024
eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma.
eIF3f promotes tumour malignancy by remodelling fatty acid biosynthesis in hepatocellular carcinoma.
Journal: Journal of hepatology
Published: July 02, 2024
CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinoma.
Journal: Cancer letters
Published: December 12, 2023
Hypomethylation-enhanced CRTC2 expression drives malignant phenotypes and primary resistance to immunotherapy in hepatocellular carcinoma.
Journal: iScience
Published: July 19, 2023
Two complete mitochondrial genomes in Scolopendra and a comparative analysis of tRNA rearrangements in centipedes.
Journal: Molecular biology reports
Published: December 07, 2021
A Nanomedicine Fabricated from Gold Nanoparticles-Decorated Metal-Organic Framework for Cascade Chemo/Chemodynamic Cancer Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 22, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026